By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Commercial manufacturing and sales of pharmaceutical treatments for neurological diseases10.22M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States6.79M66.46%
China3.43M33.54%